Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of the RGS2 gene with extrapyramidal symptoms induced by treatment with antipsychotic medication.

Pharmacogenetics and genomics - 1 Jul 2007

Greenbaum Lior, Strous Rael D, Kanyas Kyra, Merbl Yifat, Horowitz Anat, Karni Osnat, Katz Elena, Kotler Moshe, Olender Tsviya, Deshpande Smita N, Lancet Doron, Ben-Asher Edna, Lerer Bernard

Abstract excerpt

OBJECTIVES: To investigate the role of genes encoding regulators of G protein signaling in early therapeutic response to antipsychotic drugs and in susceptibility to drug-induced extrapyramidal symptoms. As regulators of G protein signaling and regulators of G protein signaling-like proteins play a pivotal role in dopamine receptor signaling, genetically based, functional variation could contribute to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Antipsychotic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Haplotypes

Share to Pharmacogenetics

Share to Polymorphism, Single Nucleotide

Share to RGS Proteins

Share to Risperidone

Share to Schizophrenia

Source

Identifiers

PMID: 17558307
DOI: 10.1097/FPC.0b013e32800ffbb4

Genes

RGS2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of the RGS2 gene with extrapyramidal symptoms induced by treatment with antipsychotic medication.PMID 17558307Read ↗

Further evidence for association of the RGS2 gene with antipsychotic-induced parkinsonism: protective role of a functional polymorphism in the 3'-untranslated region.Semantic proximity Read ↗

[Polymorphism of RGS2 gene: genetic markers of risk for schizophrenia and pharmacogenetic markers of typical neuroleptics efficiency].Semantic proximity Read ↗

Association of RGS2 and RGS5 variants with schizophrenia symptom severity.Semantic proximity Read ↗

Association analysis between functional polymorphism of the rs4606 SNP in the RGS2 gene and antipsychotic-induced Parkinsonism in Japanese patients with schizophrenia: results from the Juntendo University Schizophrenia Projects (JUSP).Semantic proximity Read ↗

Analysis of genetic variations in the RGS9 gene and antipsychotic-induced tardive dyskinesia in schizophrenia.Semantic proximity Read ↗

RGS4 polymorphisms predict clinical manifestations and responses to risperidone treatment in patients with schizophrenia.Semantic proximity Read ↗

Genomewide association study of movement-related adverse antipsychotic effects.Semantic proximity Read ↗

Ethnic stratification of the association of RGS4 variants with antipsychotic treatment response in schizophrenia.Semantic proximity Read ↗

Integrating genome-wide and epigenome-wide associations for antipsychotic induced extrapyramidal side effects.Semantic proximity Read ↗

Lack of association between antipsychotic-induced Parkinsonism or its subsymptoms and rs4606 SNP of RGS2 gene in African-Caribbeans and the possible role of the medication: the Curacao extrapyramidal syndromes study X.Semantic proximity Read ↗

Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes.Semantic proximity Read ↗

A genetic dissection of antipsychotic induced movement disorders.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.